Governing AI in Regulated Pharma: Building an Audit-Ready AI Governance Framework
- 15 minutes ago
- 2 min read
The Challenge
Artificial intelligence and machine learning are moving quickly into GxP environments, from batch record review to signal detection and predictive quality monitoring.
Adoption, however, is outpacing governance. Many organizations still lack a documented 'AI playbook' that explains how a model was validated, how its decisions can be explained to an inspector, and how ongoing performance is monitored after deployment.
Without a structured governance model, AI initiatives create a new category of undocumented risk: decisions that influence product quality or patient safety but cannot be fully reconstructed or defended during a regulatory review.
The Solutions
Effective AI governance in pharma does not mean slowing innovation. It means building the documentation, oversight, and monitoring discipline around AI systems that regulators already expect from every other GxP process.
A formal AI governance framework with clear roles, accountability, and escalation paths
Risk-based classification of AI/ML models by their potential impact on product quality or safety
Documented validation, explain ability, and ongoing performance monitoring protocols
A cross-functional AI oversight committee spanning quality, IT, and business stakeholders
How REDE Consulting Is Helping
Designing AI governance frameworks aligned to current regulatory expectations
Running AI risk and model inventory assessments to surface undocumented or shadow AI use
Building inspection-ready documentation templates for model validation and monitoring
Developing AI-specific policies and SOPs that integrate with existing quality systems
Providing ongoing advisory as AI regulation and inspector expectations continue to evolve
Get In Touch
About REDE Consulting
REDE Consulting is a leading advisory firm specializing in regulatory compliance and governance in the pharmaceutical industry. With a focus on integrating advanced technologies, including artificial intelligence (AI), into existing frameworks, REDE Consulting helps organizations navigate the complexities of regulatory requirements while maximizing the benefits of AI innovations.
Our Mission
Our mission is to empower pharmaceutical companies to implement robust AI governance frameworks that ensure compliance, enhance operational efficiency, and promote ethical use of AI technologies.
Services Offered
AI Governance Framework Development: Tailoring governance structures to meet regulatory standards and industry best practices.
Regulatory Compliance Audits: Conducting comprehensive audits to ensure adherence to regulatory requirements.
Training and Workshops: Providing educational resources to equip teams with the knowledge needed for effective AI governance.
Risk Management Strategies: Developing strategies to identify, assess, and mitigate risks associated with AI implementation.
Why Choose REDE Consulting?
With a team of experts experienced in both regulatory affairs and AI technologies, REDE Consulting offers a unique perspective that bridges the gap between compliance and innovation. Our tailored approach ensures that your organization is not only audit-ready but also positioned for future success in an evolving regulatory landscape.
If your organization is looking to strengthen its IRM/GRC program, REDE Consulting can help you assess your current maturity, close critical gaps, and build a framework that scales as your business grows.
Reach out to our team at evita@rede-consulting.com to schedule a consultation and learn how REDE Consulting can support your pharmaceutical risk and compliance strategy.
Comments